Clinical trials of HCC in taiwan

Hepato-Gastroenterology

Volumn 45, Issue 24, 1998, Pages 1937-1943

  Whang Peng, Jacqueline ^b   Chao, Yee ^a  

^a Division of Gastroenterology   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Vitamin K (K3)(menadione)

Indexed keywords

ALPHA INTERFERON; CAMPTOTHECIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOKINE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FLUTAMIDE; FOLINIC ACID; GANCICLOVIR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IODINATED POPPYSEED OIL; IODINE 131; IRINOTECAN; MEGESTROL ACETATE; MENADIOL SODIUM PHOSPHATE; MENADIONE; PACLITAXEL; PLASMID DNA; PSEUDOMONAS EXOTOXIN; RADIOISOTOPE; RECOMBINANT ALPHA2A INTERFERON; RETINOIC ACID; RHENIUM 188; TAMOXIFEN; VERAPAMIL; VINCRISTINE; VITAMIN K GROUP;

ALLERGY; AREA UNDER THE CURVE; CANCER MORTALITY; CASE CONTROL STUDY; CHEMOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; CONSERVATIVE TREATMENT; DRUG RESPONSE; GENE THERAPY; HEPATITIS B VIRUS; HUMAN; INFECTION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LD 50; LEUKOPENIA; LIVER CELL CARCINOMA; META ANALYSIS; NEUTROPENIA; NONHUMAN; ORAL DRUG ADMINISTRATION; PALLIATIVE THERAPY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENT DISEASE; SUBCUTANEOUS DRUG ADMINISTRATION; TAIWAN; THROMBOCYTOPENIA; VOMITING;

EID: 0032439148     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Beasley RP, Hwang LY, Lin CC, et al: Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22707 men in Taiwan. Lancet 1981; 2:1129.
2. Felicia YH Wu, Nien-Tzu Chang, Wen-Jer Chen, Chung-Ching Juan: Vitamin K3-induced cell cycle arrest and apoptotic cell death are accompanied by altered expression of c-fos and c-myc in nasopharyngeal carcinoma cells. Oncogene 1993; 8:2237-2244.
3. Chlebowski RT, Dietrich M, Akman S, Block JB: Vitamin K3 inhibition of malignant murine cell growth and human tumor colony formation. Cancer Treatment Reports 1985; 69(5):527-532.
4. Umesono K, Giguere V, Glass CK, Rosenfeld MG, Evans RN: Retinoic acid and thyroid hormone induce gene expression through a common responsive element. Nature 1988; 336:262-265.
5. Elias PM, Williams ML: Retinoids, camcer and skin. Arch Dermatol 1981; 117:160-180.
6. Chen MF, Hwang TC, et al: Post-operative recurrence of hepatocellular carcinoma: 205 consecutive patients who underwent hepatic resection in 15 years. Arch Surg 1994; 129:738-742.
7. Belghiti J, Panis Y, Farges O, Benhamous JP, Fekete F: Intrahepatic recurrence after resection of hepatocellular carcinoma. Complicating cirrhosis. Ann Surg. 1991; 214:114-117.
8. Nakajima Y, Takashi O, Kimura J, Shimamura T, Misawa K, Matsushita M, Sato N, Une Y, Uchino J: Role of surgical treatment for recurrent hepatocellular carcinoma after hepatic resection. World J Surg 1993; 17:792-795.
9. Beasley RP: Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988; 61:1942-1956.
10. Dunk AA, Ikeda T, Pignatelli M, Thomas HC: Human lymphoblastoid interferon: in vitro and in vivo studies in hepatocellular carcinoma. J Hepatol 1986; 2:419-429.
11. Chao Y, Chan WK, Huang YS, Teng HC, Wang SS, Lui WY, Whang-Peng J, Lee SD: Phase II study of Flutamide in the treatment of hepatocellular carcinoma. Cancer 1996; 77:635-639.
12. Li LH, Fraser TJ, Olin EJ, et al: Action of Camptothecin on mammalian cells in cultures. Cancer Research 1972; 32:2643-2650.
13. Gallo RC, Whang-Peng J, Adamson RH: Studies on the antitumor activity, mechanism of action, and cell cycle effects of Camptothecin. J Natl Cancer Inst 1971; 46:789-795.
14. DOx-SL (formerly Doxil) Investigator's Brochure, Preclinical Studies, April 14, 1993.
15. Northfelt DW, Martin FJ, Kaplan LD, Russell J, Anderson M, Lang J, Volberding PA: Pharmacokinetics, tumor locatization and safety of DOx-SL (formerly Doxil) in AIDS patients with Kaposi's sarcoma. Proceedings American Society of Clinical Oncology 12 1993; 8:51.
16. Sciarrino E, Simonetti R, LeMoli S, et al: Adriamycin treatment for hepatocellular carcinoma: Experience with 109 patients. Cancer 1985; 56:2751-2754.